NCT00372437 2015-07-01A Phase I/II Study of MGCD0103 (MG-0103) in Combination With GemcitabineMirati Therapeutics Inc.Phase 1/2 Completed47 enrolled
NCT00323934 2015-01-08Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaMirati Therapeutics Inc.Phase 1 Completed42 enrolled